Target Price | JPY1,679.17 |
Price | JPY1,393.00 |
Potential |
20.54%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target Astellas Pharma 2026 .
The average Astellas Pharma target price is JPY1,679.17.
This is
20.54%
register free of charge
JPY2,200.00
57.93%
register free of charge
JPY1,300.00
6.68%
register free of charge
|
|
A rating was issued by 13 analysts: 5 Analysts recommend Astellas Pharma to buy, 7 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Astellas Pharma stock has an average upside potential 2026 of
20.54%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 1,912.32 | 1,948.05 |
19.25% | 1.87% | |
EBITDA Margin | 9.26% | 22.01% |
33.56% | 137.78% | |
Net Margin | 2.65% | 7.42% |
149.67% | 179.61% |
12 Analysts have issued a sales forecast Astellas Pharma 2026 . The average Astellas Pharma sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Astellas Pharma EBITDA forecast 2026. The average Astellas Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Astellas Pharma Analysts have issued a net profit forecast 2026. The average Astellas Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 28.34 | 80.79 |
199.26% | 185.07% | |
P/E | 17.24 | |
EV/Sales | 1.60 |
6 Analysts have issued a Astellas Pharma forecast for earnings per share. The average Astellas Pharma EPS is
This results in the following potential growth metrics and future valuations:
Astellas Pharma...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.